Serina Therapeutics, Inc. (SER) Capital expenditures 2017–2025
Serina Therapeutics, Inc. (SER) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$59,000FY2025 · since FY2017: $1,000 → $59,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $59,000 | +168.2% |
| FY2024 | $22,000 | — |
| FY2020 | $20,000 | -96.9% |
| FY2019 | $641,000 | +2952.4% |
| FY2018 | $21,000 | +2000.0% |
| FY2017 | $1,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice